Checking your sign-in status…

Private workspace

Finance

Research, portfolio tools, and market analysis in one place.

Finance home
Back to US Equities

US Equities · Finance research note

BLDR — Builders FirstSource

Research and analysis only
View analysis Browse US Equities

Evidence and analysis

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

2. Company Fundamentals

2.1 Competitiveness

Metric Value
Operating Margins 0.5%
Profit Margins 1.97%
Return on Equity 6.96%
Return on Assets 3.4%
Free Float 0.1B
Short Int % Utilisation 9.77%

2.2 Growth

Metric Value
Revenue Growth -10.1%
Free Cash Flow 0.64B
EBITDA 10.94 (Ratio)
Enterprise Value 13.22B
EV/Revenue 0.89
EV/EBITDA 10.94

Revenue growth of -10.1% suggests mature or challenged top-line momentum.

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.)* -40.31%
Risk / Std Dev (Ann.)* 50.28%
1-Year Price Return* -47.03%

Latest Market Data (as of 2026-08-14, US Eastern time):

Metric Value
Last Price $72.51
52-Week Range $65.10 – $151.03
Observation Count 251 trading days

The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.

DuPont Model Analysis

The DuPont model decomposes return on equity (ROE) into three operating and capital-structure drivers:

ROE = Net Margin × Asset Turnover × Equity Multiplier

The comparison uses the latest two comparable annual periods available for the issuer, with reported statement amounts shown in US$. Revenue and net income are income-statement flows; total assets and shareholders’ equity are year-end balance-sheet figures. This is a simplified year-end-balance DuPont comparison rather than an average-balance ROE calculation.

DuPont component Calculation FY2025 FY2024
Revenue Reported revenue $15.19B $16.40B
Net income Reported net income $435.20M $1.08B
Total assets Year-end reported balance $11.24B $10.58B
Shareholders’ equity Year-end reported balance $4.35B $4.30B
Net margin Net income ÷ revenue 2.86% 6.57%
Asset turnover Revenue ÷ total assets 1.3518x 1.5497x
Equity multiplier Total assets ÷ shareholders’ equity 2.5820x 2.4632x
ROE Net margin × asset turnover × equity multiplier 10.00% 25.09%

Source: Yahoo Finance annual statements. Values are based on the two latest comparable annual periods returned by the source; fiscal period labels use the statement period-end year.

2.5 FCFF DCF Valuation

Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.

Step 1 — Forecast Operating Profit and NOPAT

Reported operating input Value
Revenue $15.19B
Prior annual revenue $16.40B
EBIT $786.28M
Tax rate 15.06%
NOPAT = EBIT × (1 − tax rate) $667.83M
Forecast start-growth basis -7.38%
Forecast policy latest reported annual revenue growth, bounded to -10.00% / 15.00%

Step 2 — Calculate FCFF

Current FCFF building block Value
NOPAT $667.83M
Add: depreciation & amortisation $591.43M
Less: capital expenditure -$362.60M
Less/(add): working-capital cash-flow movement $125.94M
Current unlevered FCFF $1.02B

Explicit FCFF forecast

Forecast year Revenue growth NOPAT D&A Capex Change in NWC FCFF Present value
1 -7.38% $618.57M $547.80M -$335.85M $116.65M $947.17M $905.48M
2 -4.91% $588.21M $520.92M -$369.76M $110.93M $850.30M $742.88M
3 -2.44% $573.87M $508.22M -$409.90M $108.22M $780.41M $623.12M
4 0.03% $574.04M $508.37M -$459.20M $108.26M $731.47M $533.76M
5 2.50% $588.40M $521.08M -$521.08M $110.96M $699.36M $466.39M

Step 3 — Determine the Discount Rate (WACC)

WACC input Value
Risk-free rate 4.71%
Equity risk premium assumption 5.50%
Beta 1.42
Cost of equity 12.51%
Pre-tax cost of debt 5.81%
WACC 9.42%
WACC validation within standard range

Step 4 — Estimate Terminal Value

Terminal-value input Value
Perpetuity growth rate 2.50%
Terminal value $10.36B
Implied terminal EV / EBITDA 8.53x
Terminal value as % of enterprise value 66.87%

Step 5 — Discount Cash Flows to Enterprise Value

Enterprise-value component Value
Present value of explicit FCFF $3.27B
Present value of terminal value $6.60B
Indicated enterprise value $9.87B
Discounting convention mid-year for explicit FCFF; terminal value discounted at year-end five

Step 6 — Convert Enterprise Value to Equity Value

Equity bridge Value
Indicated enterprise value $9.87B
Less: gross interest-bearing debt $5.10B
Add: cash and equivalents $181.75M
Add: affiliate investments $0.00
Less: minority interests $0.00
Indicated common equity value $4.96B

Step 7 — Calculate Indicative Value Per Share

Per-share output Value
Shares used 111,800,000.00
Share-count basis reported diluted weighted-average shares
Current market price $68.86
DCF indicative value per share $44.33
Indicative value vs. market price -35.62%

Model Integrity Checks

Check Result
Perpetuity growth is below the risk-free rate pass
Perpetuity growth is below WACC pass
WACC is within the configured operating-company range pass
Terminal-year FCFF is positive pass
Terminal capex converges to D&A pass
Terminal-value concentration within review band
Implied price differs from spot by more than 30% review required

2.6 Investor-Style Research Screen

Educational screen Result
Buffett-inspired cash-quality checks 3/4 evidenced checks
Lynch-inspired balance-and-growth checks 3/4 evidenced checks

Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 17:24:47.510339 UTC; latest reported fiscal period: 2025-12-31 00:00:00. Default assumptions: five-year forecast, mid-year discounting for explicit FCFF, a maximum 2.50% perpetuity-growth rate below both WACC and the risk-free rate, historical operating-ratio persistence, and capex convergence to D&A by year five. No sell-side consensus or management guidance is substituted for reported inputs. This is research and analysis only, not personalized financial advice.

2.7 Quantitative Factor Diagnostics

Model basis: Daily issuer USD excess returns are regressed in-sample using ordinary least squares on matching regional Fama–French factors. FF3 estimates market, size, and value loadings; FF5 adds profitability and investment. Coefficients are descriptive historical exposures, not predictions.

Estimation input Value
Regional factor set US
Factor-return currency USD
Issuer-return basis USD adjusted total return
Estimation window 2025-08-19 to 2026-06-30
Aligned daily observations 217
Minimum observation requirement 120
Currency conversion for HK listings not required

Fama–French Three-Factor and Five-Factor Results

Diagnostic FF3 FF5
Annualised alpha -58.08% -44.40%
Adjusted R² 0.36 0.44
Annualised residual volatility 39.12% 36.39%
Factor loading (t-statistic) FF3 FF5
Market excess return (Mkt-RF) 1.40 (6.07) 2.03 (8.25)
Size (SMB) 2.03 (6.54) 1.83 (5.84)
Value (HML) 0.34 (1.28) -0.58 (-1.87)
Profitability (RMW) NM 0.80 (3.05)
Investment (CMA) NM 1.84 (4.08)

Definitions: Mkt-RF is the market return less the risk-free rate; SMB is small minus big; HML is high minus low book-to-market; RMW is robust minus weak profitability; CMA is conservative minus aggressive investment. Factor returns are sourced from the Kenneth R. French Data Library; issuer adjusted-return history is sourced from Yahoo Finance. For Hong Kong listings, adjusted HKD prices are converted into USD with daily USD/HKD closes before return calculation to match the USD regional factor basis. This is an in-sample historical regression; coefficients and t-statistics do not establish causation or predict future returns. This is research and analysis only, not personalized financial advice.

us-equitystockequitybldrindustrialsbuilding-productsnasdaq